Amino Acid Disorders 2
The Amino Acid Disorders 2 session will be discussing PKU, Tyrosinemia, Homocystinuria (including cobalamin G&E metab).
This educational activity is supported by an educational grant from Ultragenyx.
At the conclusion of this educational series, participants should be able to:
- Understand the metabolic fate of different amino acids in humans
- Recognize the variety of therapeutic approaches available for phenylketonuria and other amino acidopathies
- Identify at least multiple causes of hyperhomocysteinemia
Shawn McCandless, MD
University of Colorado
Shawn McCandless, MD, speaker for this activity, is a consultant for Levo Therapeutics, a speaker for Horizon Therapeutics and a researcher for Aardvark Therapeutics, Ultragenyx and Harmony Therapeutics.
Planners, faculty, and others in control of content (either individually or as a group) have no relevant financial relationships with ineligible companies.
All of the relevant financial relationships listed have been mitigated.
Children’s Hospital Colorado is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Children’s Hospital Colorado designates this Live activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
A general certificate of attendance will be available after the completion of the online evaluation. Claim only credit commensurate of your conference attendance.
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Attendance